查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1547522

全球熱療癌症治療市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

Global Hyperthermia Cancer Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

全球熱療癌症治療市場的市場規模預計將從 2023 年的 1.8699 億美元達到 2032 年的近 3.3098 億美元，2024-2032 年研究期間複合年成長率為 6.55%。

熱療癌症治療是利用熱能破壞和殺死癌細胞的熱療法。身體組織暴露在高達 113°F 的高溫下。透過這樣做，癌細胞可能會縮小腫瘤。熱療的有效性取決於治療期間達到的溫度、治療時間以及細胞和組織特徵。熱療癌症治療可單獨或與化療和放射治療合併進行。

市場動態

全球熱療癌症治療市場正處於起步階段。全球癌症負擔的增加以及對其有效性的研究預計將推動對熱療癌症治療的需求。癌症是主要死亡原因，2020 年將導致近 1000 萬人死亡。許多臨床試驗已經檢驗了熱療與化療和放射治療的結合。該研究取得了有利於商業用途的改進和進步結果，為市場創造了利潤豐厚的機會。然而，熱療可能會使一些癌細胞對輻射更加敏感，導致皮膚不適或局部疼痛、水泡，有時甚至燒傷，從而抑制市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球熱療癌症治療市場的各個細分市場進行了包容性評估。熱療癌症治療產業的成長和趨勢為本研究提供了整體方法。

市場區隔

熱療癌症治療市場報告的這一部分提供了有關國家和區域層面細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

依設備類型

  • 紅外線熱療儀
  • 超音波熱療儀
  • 微波熱療設備
  • 其他

依治療方法

  • 局部方法（外部和間質、腔內或腔內方法、連續高溫腹膜灌注 (CHPP)、深層組織和區域灌注）
  • 全身

按申請

  • 乳癌
  • 肝癌
  • 軟組織肉瘤
  • 頭頸腫瘤
  • 攝護腺癌
  • 其他

按最終用戶

  • 醫院和專科診所
  • 門診手術中心
  • 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲熱療癌症治療市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。熱療癌症治療市場的主要參與者包括 Pyrexar Medical、Celsius42 GmbH、Hydrosun GmbH、Oncotherm Kft、Andromedic SRL、YamamotVinita Co. Ltd.、重慶海扶醫療科技有限公司、InnoMedicus Ltd.、Gamida、RanD。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：熱療癌症治療 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 按設備類型分類的市場吸引力分析
    • 按處理方法進行的市場吸引力分析
    • 市場吸引力分析：依應用分類
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球熱療癌症治療市場分析：按設備類型

  • 按設備類型概述
  • 按設備類型進行歷史和預測資料分析
  • 紅外線熱療儀
  • 超音波熱療儀
  • 微波熱療設備
  • 其他

第 6 章：全球熱療癌症治療市場分析：依治療方法分類

  • 依治療方法概述
  • 依處理方法進行歷史和預測資料分析
  • 局部方法（外部和間質、腔內或腔內方法、連續高溫腹膜灌注 (CHPP)、深層組織和區域灌注）
  • 全身

第 7 章：全球熱療癌症治療市場分析：按應用分類

  • 概述：按應用
  • 歷史和預測數據分析：按應用
  • 乳癌
  • 肝癌
  • 軟組織肉瘤
  • 頭頸腫瘤
  • 攝護腺癌
  • 其他

第 8 章：全球熱療癌症治療市場分析：依最終使用者分類

  • 最終用戶概述
  • 最終用戶的歷史和預測數據分析
  • 醫院和專科診所
  • 門診手術中心
  • 其他

第 9 章：全球熱療癌症治療市場分析：依地理位置

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區按國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概覽、歷史與預測資料銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲按國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 10 章：熱療癌症治療公司的競爭格局

  • 熱療癌症治療市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • Pyrexar Medical
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Celsius42 GmbH
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Hydrosun GmbH
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Oncotherm Kft
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Andromedic SRL
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • YamamotVinita Co. Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Chongqing Haifu Medical Technology Co. Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • InnoMedicus Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Gamida
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • RanD
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

Product Code: VMR11215080

The global demand for Hyperthermia Cancer Treatment Market is presumed to reach the market size of nearly USD 330.98 Million by 2032 from USD 186.99 Million in 2023 with a CAGR of 6.55% under the study period 2024-2032.

Hyperthermia cancer treatment is thermotherapy in which cancer cells are damaged and killed using thermal energy. The body tissues are exposed to high temperatures of up to 113°F. By doing this, cancer cells may shrink tumors. The effectiveness of hyperthermia therapy is dependent on the temperature achieved during the treatment, length of treatment, and cell and tissue characteristics. Hyperthermia cancer treatment is carried out alone or in combination with chemotherapy and radiation therapy.

MARKET DYNAMICS

The global hyperthermia cancer treatment market is at its nascent stage. Mounting cancer burden worldwide and spurring research on its effectiveness is projected to propel the demand for hyperthermia cancer treatment. Cancer is the primary cause of death, accounting for nearly 10 million deaths in 2020. The cancer prevalence increases every day with rising alcohol & tobacco consumption, exposure to ultraviolet radiation, and an unhealthy lifestyle. Numerous clinical trials have examined hyperthermia in combination with chemotherapy and radiation therapy. The research has witnessed improved and progressive results favorable for commercial use, creating lucrative opportunities for the market. However, hyperthermia treatment may make some cancer cells more sensitive to radiation, cause skin discomfort or local pain, blisters, and sometimes burns, restraining market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Hyperthermia Cancer Treatment. The growth and trends of Hyperthermia Cancer Treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Hyperthermia Cancer Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Device Type

  • Infrared Hyperthermia Devices
  • Ultrasound Hyperthermia Devices
  • Microwave Hyperthermia Devices
  • Others

By Treatment Method

  • Locoregional Method (External & Interstitial, Intraluminal or Endocavitary Methods, Continuous Hyperthermic Peritoneal Perfusion (CHPP), Deep Tissue & Regional Perfusion)
  • Whole-body

By Application

  • Breast Cancer
  • Liver Cancer
  • Soft Tissue Sarcoma
  • Head & Neck Tumors
  • Prostate Cancer
  • Others

By End User

  • Hospitals & Specialty Clinics
  • Ambulatory Surgical Centers
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Hyperthermia Cancer Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Hyperthermia Cancer Treatment market include Pyrexar Medical, Celsius42 GmbH, Hydrosun GmbH, Oncotherm Kft, Andromedic S.R.L., YamamotVinita Co. Ltd., Chongqing Haifu Medical Technology Co. Ltd., InnoMedicus Ltd., Gamida, RanD. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. HYPERTHERMIA CANCER TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Device Type
    • 3.7.2 Market Attractiveness Analysis By Treatment Method
    • 3.7.3 Market Attractiveness Analysis By Application
    • 3.7.4 Market Attractiveness Analysis By End User
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET ANALYSIS BY DEVICE TYPE

  • 5.1. Overview By Device Type
  • 5.2. Historical and Forecast Data Analysis By Device Type
  • 5.3. Infrared Hyperthermia Devices Historic and Forecast Sales By Regions
  • 5.4. Ultrasound Hyperthermia Devices Historic and Forecast Sales By Regions
  • 5.5. Microwave Hyperthermia Devices Historic and Forecast Sales By Regions
  • 5.6. Others Historic and Forecast Sales By Regions

6. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET ANALYSIS BY TREATMENT METHOD

  • 6.1. Overview By Treatment Method
  • 6.2. Historical and Forecast Data Analysis By Treatment Method
  • 6.3. Locoregional Method (External & Interstitial, Intraluminal or Endocavitary Methods, Continuous Hyperthermic Peritoneal Perfusion (CHPP), Deep Tissue & Regional Perfusion) Historic and Forecast Sales By Regions
  • 6.4. Whole-body Historic and Forecast Sales By Regions

7. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET ANALYSIS BY APPLICATION

  • 7.1. Overview By Application
  • 7.2. Historical and Forecast Data Analysis By Application
  • 7.3. Breast Cancer Historic and Forecast Sales By Regions
  • 7.4. Liver Cancer Historic and Forecast Sales By Regions
  • 7.5. Soft Tissue Sarcoma Historic and Forecast Sales By Regions
  • 7.6. Head & Neck Tumors Historic and Forecast Sales By Regions
  • 7.7. Prostate Cancer Historic and Forecast Sales By Regions
  • 7.8. Others Historic and Forecast Sales By Regions

8. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET ANALYSIS BY END USER

  • 8.1. Overview By End User
  • 8.2. Historical and Forecast Data Analysis By End User
  • 8.3. Hospitals & Specialty Clinics Historic and Forecast Sales By Regions
  • 8.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
  • 8.5. Others Historic and Forecast Sales By Regions

9. GLOBAL HYPERTHERMIA CANCER TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE HYPERTHERMIA CANCER TREATMENT COMPANIES

  • 10.1. Hyperthermia Cancer Treatment Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF HYPERTHERMIA CANCER TREATMENT INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Pyrexar Medical
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Celsius42 GmbH
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Hydrosun GmbH
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Oncotherm Kft
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Andromedic S.R.L.
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. YamamotVinita Co. Ltd.
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Chongqing Haifu Medical Technology Co. Ltd.
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. InnoMedicus Ltd.
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Gamida
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. RanD
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Device Type (USD MN)
  • Infrared Hyperthermia Devices Market Sales By Geography (USD MN)
  • Ultrasound Hyperthermia Devices Market Sales By Geography (USD MN)
  • Microwave Hyperthermia Devices Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Treatment Method (USD MN)
  • Locoregional Method (External & Interstitial, Intraluminal or Endocavitary Methods, Continuous Hyperthermic Peritoneal Perfusion (CHPP), Deep Tissue & Regional Perfusion) Market Sales By Geography (USD MN)
  • Whole-body Market Sales By Geography (USD MN)
  • Analysis By Application (USD MN)
  • Breast Cancer Market Sales By Geography (USD MN)
  • Liver Cancer Market Sales By Geography (USD MN)
  • Soft Tissue Sarcoma Market Sales By Geography (USD MN)
  • Head & Neck Tumors Market Sales By Geography (USD MN)
  • Prostate Cancer Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By End User (USD MN)
  • Hospitals & Specialty Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Hyperthermia Cancer Treatment Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Hyperthermia Cancer Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Hyperthermia Cancer Treatment Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Device Type
  • Market Attractiveness Analysis By Treatment Method
  • Market Attractiveness Analysis By Application
  • Market Attractiveness Analysis By End User
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Device Type (USD MN)
  • Infrared Hyperthermia Devices Market Sales By Geography (USD MN)
  • Ultrasound Hyperthermia Devices Market Sales By Geography (USD MN)
  • Microwave Hyperthermia Devices Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Treatment Method (USD MN)
  • Locoregional Method (External & Interstitial, Intraluminal or Endocavitary Methods, Continuous Hyperthermic Peritoneal Perfusion (CHPP), Deep Tissue & Regional Perfusion) Market Sales By Geography (USD MN)
  • Whole-body Market Sales By Geography (USD MN)
  • Global Market Analysis By Application (USD MN)
  • Breast Cancer Market Sales By Geography (USD MN)
  • Liver Cancer Market Sales By Geography (USD MN)
  • Soft Tissue Sarcoma Market Sales By Geography (USD MN)
  • Head & Neck Tumors Market Sales By Geography (USD MN)
  • Prostate Cancer Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By End User (USD MN)
  • Hospitals & Specialty Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.